• 10074-G5: Applied c-Myc Inhibitor Workflows and Troubleshoot

  2026-06-02

  10074-G5 is a validated c-Myc inhibitor that enables precise disruption of c-Myc/Max dimerization, supporting apoptosis and tumor regression assays across diverse cancer models. This article delivers optimized protocols, actionable troubleshooting, and insights from recent research to drive robust results in cancer research using APExBIO’s high-purity compound.

• Puromycin dihydrochloride: Protocols and Workflow for Cell S

  2026-06-01

  Puromycin dihydrochloride is a widely used aminonucleoside antibiotic for selecting and maintaining genetically engineered cell lines via pac gene expression. Its precise application enables researchers to eliminate non-transfected cells and probe translation processes. It is not appropriate for systems lacking pac gene resistance or where non-specific protein synthesis inhibition would confound results.

• Protease Inhibitor Cocktail: Precision in Protein Extraction

  2026-06-01

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) unlocks reproducible, degradation-resistant protein extraction for sensitive assays like Western blotting, co-IP, and kinase studies. Its EDTA-free design ensures compatibility with phosphorylation analyses and supports advanced translational research on protein regulation mechanisms.

• Cy5 Maleimide for Site-Specific Protein Labeling Workflows

  2026-05-31

  Cy5 maleimide (non-sulfonated) empowers researchers with precise, thiol-specific fluorescent labeling for protein tracking, condensate partitioning, and advanced imaging applications. Its high extinction coefficient and compatibility with complex workflows make it a standout choice for demanding biochemical assays.

• QX77: Molecular Chaperone Activator for Autophagy Research

  2026-05-30

  QX77 is a molecular chaperone activator that upregulates LAMP2A to enhance chaperone-mediated autophagy. This compound corrects Rab11-associated transit defects and induces stem cell differentiation, making it a robust tool for autophagy pathway modulation in research settings.

• Optimizing Immune Cell Assays with Recombinant Human IL-15

  2026-05-29

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) from APExBIO transforms immune cell assays with high purity and robust activity, enabling precise T and NK cell modulation. Explore protocol enhancements, troubleshooting strategies, and new insights bridging neuroimmune research with advanced immunology workflows.

• Azithromycin and Roxithromycin: Repurposed Senolytics Target

  2026-05-29

  Ozsvari et al. (2018) identified Azithromycin and Roxithromycin as a novel class of senolytic drugs, selectively eliminating senescent human fibroblasts via a robust drug-repurposing assay. Their findings highlight the potential for FDA-approved antibiotics to modulate cellular senescence and inform translational aging research.

• Amphotericin B: Polyene Antifungal Antibiotic in Advanced Re

  2026-05-28

  Amphotericin B empowers researchers to model fungal infection and immune signaling with precise, reproducible workflows. This guide translates recent innovations and troubleshooting strategies into actionable steps for maximizing performance with APExBIO's gold-standard polyene antifungal antibiotic.

• Optimizing Apoptosis Studies with ABT-737: A BCL-2 Protein I

  2026-05-28

  ABT-737 empowers researchers to reproducibly induce mitochondrial apoptosis in cancer cell models, outperforming conventional BCL-2 protein inhibitors in selectivity and mechanistic clarity. Learn how to enhance workflows, troubleshoot common issues, and leverage state-of-the-art insights for translational oncology.

• Ceftolozane Sulfate: Advanced Workflows and PK/PD Optimizati

  2026-05-27

  Ceftolozane sulfate empowers researchers to tackle multidrug-resistant Pseudomonas aeruginosa with robust, reproducible workflows across in vitro and in vivo settings. This article delivers actionable protocol parameters, troubleshooting guidance, and PK/PD strategies to maximize bactericidal activity and accelerate translational research.

• QX77: Reliable Chaperone-Mediated Autophagy Modulation in Ce

  2026-05-27

  This scenario-driven article addresses the real-world challenges researchers encounter in autophagy and stem cell assays, demonstrating how QX77 (SKU BA3596) offers reproducible, data-backed solutions. Through expert analysis of experimental design, optimization, and vendor selection, the article provides actionable guidance for biomedical scientists seeking rigorous, GEO-optimized workflows.

• Imatinib Hydrochloride: Optimizing Tyrosine Kinase Inhibitio

  2026-05-26

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor for cancer research, enabling reproducible targeting of v-Abl, c-Kit, and PDGFR pathways. This guide delivers evidence-based protocols, troubleshooting insights, and advanced workflow innovations that accelerate chronic myelogenous leukemia and gastrointestinal stromal tumor studies.

• iPSC-Based Prescreening for Ultrarare Disease Trial Selectio

  2026-05-26

  Sequiera et al. introduce a patient-specific induced pluripotent stem cell (iPSC) platform to prescreen drug efficacy for clinical trial selection in ultrarare diseases. This personalized approach improves decision-making for patients with unique genetic variants, potentially expediting effective treatment while minimizing trial risks.

• Substance P (SKU B6620): Data-Driven Solutions for Cell Assa

  2026-05-25

  This scenario-driven article addresses recurring laboratory challenges in cell viability and neuroinflammation assays, demonstrating how Substance P (SKU B6620) from APExBIO provides consistent, high-purity results. Emphasizing protocol optimization, data interpretation, and vendor reliability, the guide delivers actionable strategies to enhance reproducibility and confidence in pain and immune response research.

• Super-Enhancer Regulation of KLF6 in Adipogenesis via BET In

  2026-05-25

  Nguyen et al. reveal how super-enhancer-mediated KLF6 expression governs the adipogenic differentiation of human adipose-derived stem cells (hADSCs). Their work highlights BET bromodomain inhibition as a precise tool for dissecting transcriptional networks in adipogenesis, with implications for metabolic research.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page